James Basta - Net Worth and Insider Trading
James Basta Net Worth
The estimated net worth of James Basta is at least $857,042 dollars as of 2024-11-13. James Basta is the EVP, General Counsel of Intellia Therapeutics Inc and owns about 51,474 shares of Intellia Therapeutics Inc (NTLA) stock worth over $857,042. Details can be seen in James Basta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Basta has not made any transactions after 2024-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Basta
James Basta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Basta owns 2 companies in total, including Kura Oncology Inc (KURA) , and Intellia Therapeutics Inc (NTLA) .
Click here to see the complete history of James Basta’s form 4 insider trades.
Insider Ownership Summary of James Basta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KURA | Kura Oncology Inc | 2019-11-04 | Chief Legal Officer |
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | EVP & General Counsel |
James Basta Latest Holdings Summary
James Basta currently owns a total of 1 stock. James Basta owns 51,474 shares of Intellia Therapeutics Inc (NTLA) as of January 3, 2024, with a value of $857,042.
Latest Holdings of James Basta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | 51,474 | 16.65 | 857,042 |
Holding Weightings of James Basta
James Basta Form 4 Trading Tracker
According to the SEC Form 4 filings, James Basta has made a total of 2 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 3,805 shares on January 3, 2024, which brought James Basta around $112,095.
Insider Trading History of James Basta
- 1
James Basta Trading Performance
James Basta Ownership Network
Ownership Network List of James Basta
Ownership Network Relation of James Basta
James Basta Owned Company Details
What does Kura Oncology Inc do?
Who are the key executives at Kura Oncology Inc?
James Basta is the Chief Legal Officer of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Legal Officer Teresa Brophy Bair , Chief Medical Officer Stephen Dale , and SVP & Finance & Accounting Thomas James Doyle .
Kura Oncology Inc (KURA) Insider Trades Summary
Over the past 18 months, James Basta made no insider transaction in Kura Oncology Inc (KURA). Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 4,668 shares made by Teresa Brophy Bair , a net sale of 91,052 shares made by Troy Edward Wilson , and a net purchase of 50,000 shares made by Thomas Malley .
In summary, during the past 3 months, insiders sold 0 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 111,517 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 61,517 shares.
Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kura Oncology Inc Insider Transactions
James Basta Mailing Address
Above is the net worth, insider trading, and ownership report for James Basta. You might contact James Basta via mailing address: C/o Kura Oncology, Inc., 3033 Science Park Rd, Suite 220, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
